Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.75B | 4.70B | 4.64B | 4.47B | 3.96B | 5.16B | Gross Profit |
1.83B | 1.85B | 1.66B | 1.63B | 491.00M | 836.00M | EBIT |
136.00M | 95.00M | 40.00M | 141.00M | 151.00M | 366.00M | EBITDA |
434.00M | 392.00M | 307.00M | 273.00M | 281.00M | 548.00M | Net Income Common Stockholders |
-4.00M | -31.00M | -76.00M | -14.00M | -47.00M | 198.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
389.00M | 28.00M | 54.00M | 111.00M | 175.00M | 389.00M | Total Assets |
5.41B | 5.00B | 4.77B | 5.05B | 4.57B | 5.41B | Total Debt |
2.06B | 2.12B | 1.94B | 2.07B | 1.52B | 2.06B | Net Debt |
1.68B | 2.10B | 1.88B | 1.97B | 1.35B | 1.68B | Total Liabilities |
3.46B | 3.23B | 2.99B | 3.13B | 2.64B | 3.46B | Stockholders Equity |
1.75B | 1.72B | 1.74B | 1.87B | 1.88B | 1.75B |
Cash Flow | Free Cash Flow | ||||
79.00M | 88.00M | 159.00M | -362.00M | -90.00M | 324.00M | Operating Cash Flow |
258.00M | 272.00M | 510.00M | 144.00M | 211.00M | 587.00M | Investing Cash Flow |
-144.00M | -150.00M | -332.00M | -486.00M | -247.00M | -203.00M | Financing Cash Flow |
-114.00M | -149.00M | -225.00M | 272.00M | -529.00M | -156.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | C$13.79B | 16.71 | 16.68% | 1.47% | 9.80% | 60.44% | |
78 Outperform | C$2.73B | 13.46 | 11.26% | 0.40% | 5.50% | 9.93% | |
74 Outperform | C$1.81B | 11.29 | 9.65% | 4.16% | -2.58% | 100.21% | |
68 Neutral | C$98.98M | ― | -10.60% | 4.47% | -3.15% | -222.64% | |
62 Neutral | $6.94B | 11.29 | 2.95% | 3.87% | 2.70% | -24.49% | |
59 Neutral | $903.97M | ― | -0.24% | 5.25% | 2.88% | 80.95% | |
$10.10B | 16.51 | 16.78% | 1.49% | ― | ― |
Cascades Inc. announced the pricing of a private placement of US$400 million in Senior Notes due 2030, with a 6.750% interest rate. The proceeds will be used to redeem existing notes, repay part of its revolving credit facility, and cover transaction costs, potentially strengthening its financial position and operational flexibility.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. announced a proposed private offering of US$400 million in Senior Notes due 2030, with the intention to use the proceeds to redeem existing notes, repay part of its revolving credit facility, and cover transaction expenses. This move is aimed at optimizing the company’s financial structure and could enhance its market position by reducing debt and improving liquidity.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. held its Annual General Meeting of Shareholders on May 8, 2025, where all eleven proposed directors were elected by a majority vote. This election reinforces the company’s leadership team as it continues to focus on eco-friendly products and sustainable practices. The final voting results will be filed with Canadian Securities Regulators, reflecting the company’s commitment to transparency and governance.
Cascades Inc. reported its financial results for the first quarter of 2025, showing a slight increase in sales compared to the previous year, despite facing challenges such as lower volumes and higher operational costs. The company experienced a significant improvement in operating income and net earnings per share, attributed to favorable selling prices and raw material costs, as well as the depreciation of the Canadian dollar. The outlook for the second quarter is optimistic, with expected improvements in packaging and tissue performance, although macro-economic uncertainties may impact future demand.